Bio-Techne (TECH) Assets Average (2010 - 2026)
Bio-Techne (TECH) recorded quarterly Assets Average of $2.5 billion in Q1 2026, little changed quarter-over-quarter from $2.5 billion in Q4 2025, and down 4.54% on a YoY basis from $2.7 billion in Q1 2025.
Bio-Techne (TECH) Assets Average (2010 - 2026) Analysis & Trends
Bio-Techne's Assets Average history runs 17 years deep, the most recent figure standing at $2.5 billion for Q1 2026.
- In Q1 2026, Assets Average fell 4.54% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 4.54% YoY), while the FY2025 annual figure was $2.6 billion, down 1.51% from the prior year.
- Assets Average was $2.5 billion for Q1 2026 at Bio-Techne, roughly flat from $2.5 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $2.7 billion in Q4 2023 to a low of $2.3 billion in Q2 2022.
- Historically, Assets Average has averaged $2.6 billion across 5 years, with a median of $2.6 billion in 2025.
- The sharpest annual moves came in 2023 and 2025: Assets Average increased 16.38% in 2023, then decreased 6.61% in 2025.
- A 5-year view of Assets Average shows it stood at $2.4 billion in 2022, then climbed by 16.38% to $2.7 billion in 2023, then decreased by 1.45% to $2.7 billion in 2024, then slipped by 6.61% to $2.5 billion in 2025, then gained by 0.48% to $2.5 billion in 2026.
- The last three Assets Average figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 2.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.54 Bn |
| Dec 31, 2025 | 2.52 Bn |
| Sep 30, 2025 | 2.54 Bn |
| Jun 30, 2025 | 2.60 Bn |
| Mar 31, 2025 | 2.66 Bn |
| Dec 31, 2024 | 2.70 Bn |
| Sep 30, 2024 | 2.72 Bn |
| Jun 30, 2024 | 2.71 Bn |
| Mar 31, 2024 | 2.73 Bn |
| Dec 31, 2023 | 2.74 Bn |
| Sep 30, 2023 | 2.70 Bn |
| Jun 30, 2023 | 2.62 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.32 Bn |
| Jun 30, 2022 | 2.30 Bn |
| Mar 31, 2022 | 2.30 Bn |
| Dec 31, 2021 | 2.29 Bn |
| Sep 30, 2021 | 2.27 Bn |
| Jun 30, 2021 | 2.17 Bn |